应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
XOMA 标记临床研究
停牌 11-18 04:41:29 EST
40.17
+0.00
0.00%
最高
40.17
最低
40.17
成交量
0.00
今开
40.17
昨收
40.17
日振幅
0.00%
总市值
7.10亿
流通市值
2.63亿
总股本
1,768万
成交额
2.73亿
换手率
0.00%
流通股本
655.79万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
标记临床研究盘中异动 早盘股价大跌7.38%报20.21美元
市场透视 · 2025-03-10
标记临床研究盘中异动 早盘股价大跌7.38%报20.21美元
标记临床研究盘中异动 快速下挫5.73%报21.40美元
市场透视 · 2025-03-04
标记临床研究盘中异动 快速下挫5.73%报21.40美元
标记临床研究盘中异动 大幅下跌5.08%报25.40美元
市场透视 · 2025-02-19
标记临床研究盘中异动 大幅下跌5.08%报25.40美元
标记临床研究盘中异动 大幅跳水5.67%
市场透视 · 2025-02-04
标记临床研究盘中异动 大幅跳水5.67%
HC Wainwright & Co.:维持XOMA Royalty(XOMA.US)评级,由买入调整至买入评级, 目标价由123.00美元调整至104.00美元。
金融界 · 2025-02-03
HC Wainwright & Co.:维持XOMA Royalty(XOMA.US)评级,由买入调整至买入评级, 目标价由123.00美元调整至104.00美元。
标记临床研究盘中异动 快速上涨5.77%报28.25美元
市场透视 · 2025-01-16
标记临床研究盘中异动 快速上涨5.77%报28.25美元
标记临床研究盘中异动 快速拉升5.20%
市场透视 · 2025-01-14
标记临床研究盘中异动 快速拉升5.20%
标记临床研究盘中异动 早盘股价大跌5.98%
市场透视 · 2025-01-11
标记临床研究盘中异动 早盘股价大跌5.98%
标记临床研究盘中异动 下午盘急速拉升5.14%
市场资讯 · 2024-12-21
标记临床研究盘中异动 下午盘急速拉升5.14%
标记临床研究盘中异动 股价大跌5.30%报25.70美元
市场透视 · 2024-12-19
标记临床研究盘中异动 股价大跌5.30%报25.70美元
标记临床研究盘中异动 快速下跌5.45%
市场透视 · 2024-12-13
标记临床研究盘中异动 快速下跌5.45%
标记临床研究盘中异动 早盘大幅下跌5.07%报30.13美元
市场透视 · 2024-12-05
标记临床研究盘中异动 早盘大幅下跌5.07%报30.13美元
标记临床研究盘中异动 急速跳水5.24%报30.00美元
市场透视 · 2024-12-05
标记临床研究盘中异动 急速跳水5.24%报30.00美元
标记临床研究盘中异动 下午盘股价大涨5.45%报32.70美元
市场透视 · 2024-11-27
标记临床研究盘中异动 下午盘股价大涨5.45%报32.70美元
标记临床研究盘中异动 大幅下跌5.02%
市场透视 · 2024-11-13
标记临床研究盘中异动 大幅下跌5.02%
标记临床研究2024财年第三财季实现净利润-17.24百万美元,同比减少212.89%
市场透视 · 2024-11-11
标记临床研究2024财年第三财季实现净利润-17.24百万美元,同比减少212.89%
标记临床研究盘中异动 早盘快速跳水6.13%
市场透视 · 2024-11-07
标记临床研究盘中异动 早盘快速跳水6.13%
标记临床研究盘中异动 快速上涨5.06%报32.59美元
市场透视 · 2024-11-06
标记临床研究盘中异动 快速上涨5.06%报32.59美元
标记临床研究盘中异动 股价大跌6.04%
市场透视 · 2024-10-30
标记临床研究盘中异动 股价大跌6.04%
标记临床研究盘中异动 股价大跌6.52%报28.25美元
市场透视 · 2024-10-29
标记临床研究盘中异动 股价大跌6.52%报28.25美元
加载更多
公司概况
公司名称:
标记临床研究
所属市场:
NASDAQ
上市日期:
--
主营业务:
XOMA Royalty Corporation于1981年在特拉华州注册成立并于2025年5月在内华达州重新注册成立。该公司是一家生物技术版税聚合商,在帮助生物技术公司实现改善人类健康的目标方面发挥着独特的作用。该公司获得了与已授权给制药或生物技术公司的预商业化和商业化治疗候选药物相关的潜在未来经济性。
发行价格:
--
{"stockData":{"symbol":"XOMA","market":"US","secType":"STK","nameCN":"标记临床研究","latestPrice":40.17,"timestamp":1783972800000,"preClose":40.17,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":6557900,"shares":17678700,"eps":1.569394,"marketStatus":"停牌","change":0,"latestTime":"11-18 04:41:29 EST","open":40.17,"high":40.17,"low":40.17,"amount":272626784.75538,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":1.569394,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1795012200000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":517896000000,"exchange":"NASDAQ","adjPreClose":40.17,"volumeRatio":0},"requestUrl":"/m/hq/s/XOMA","defaultTab":"news","newsList":[{"id":"2518984274","title":"标记临床研究盘中异动 早盘股价大跌7.38%报20.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518984274","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518984274?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:26","pubTimestamp":1741616797,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时26分,标记临床研究股票出现异动,股价大幅跳水7.38%。截至发稿,该股报20.21美元/股,成交量1.4508万股,换手率0.12%,振幅8.57%。最近的财报数据显示,该股实现营业收入7.20百万美元,净利润-17.24百万美元,每股收益-1.59美元,毛利7.19百万美元,市盈率-6.83倍。标记临床研究股票所在的生物技术行业中,整体涨幅为0.39%。XOMA获得了与已授权给制药或生物技术公司的商业化前候选治疗相关的潜在未来经济效益。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310222637abf31101&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310222637abf31101&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XOMA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516512316","title":"标记临床研究盘中异动 快速下挫5.73%报21.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516512316","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516512316?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:05","pubTimestamp":1741025132,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时05分,标记临床研究股票出现波动,股价大幅下跌5.73%。截至发稿,该股报21.40美元/股,成交量2.8404万股,换手率0.24%,振幅4.98%。标记临床研究股票所在的生物技术行业中,整体涨幅为0.30%。XOMA获得了与已授权给制药或生物技术公司的商业化前候选治疗相关的潜在未来经济效益。当XOMA获得未来的经济权利时,卖方将获得非稀释性、无追索权的资金,这些资金可用于推进其内部候选药物或用于一般公司用途。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040205339637de0c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040205339637de0c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XOMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512162677","title":"标记临床研究盘中异动 大幅下跌5.08%报25.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512162677","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512162677?lang=zh_cn&edition=full","pubTime":"2025-02-19 00:11","pubTimestamp":1739895091,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日00时11分,标记临床研究股票出现波动,股价大幅下跌5.08%。截至发稿,该股报25.40美元/股,成交量6904股,换手率0.06%,振幅2.77%。标记临床研究股票所在的生物技术行业中,整体涨幅为0.92%。XOMA获得了与已授权给制药或生物技术公司的商业化前候选治疗相关的潜在未来经济效益。当XOMA获得未来的经济权利时,卖方将获得非稀释性、无追索权的资金,这些资金可用于推进其内部候选药物或用于一般公司用途。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219001131988a0f02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219001131988a0f02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XOMA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508125463","title":"标记临床研究盘中异动 大幅跳水5.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508125463","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508125463?lang=zh_cn&edition=full","pubTime":"2025-02-04 01:09","pubTimestamp":1738602541,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日01时09分,标记临床研究股票出现异动,股价急速下跌5.67%。截至发稿,该股报25.10美元/股,成交量1.4863万股,换手率0.13%,振幅3.14%。标记临床研究股票所在的生物技术行业中,整体跌幅为0.68%。标记临床研究公司简介:XOMA Royalty Corp是一家生物技术专利使用费聚合公司,在帮助生物技术公司实现改善人类健康的目标方面发挥着重要作用。XOMA获得了与已授权给制药或生物技术公司的商业化前候选治疗相关的潜在未来经济效益。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204010901abc127a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204010901abc127a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XOMA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508114544","title":"HC Wainwright & Co.:维持XOMA Royalty(XOMA.US)评级,由买入调整至买入评级, 目标价由123.00美元调整至104.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2508114544","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508114544?lang=zh_cn&edition=full","pubTime":"2025-02-03 19:31","pubTimestamp":1738582298,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.:维持XOMA Royalty(XOMA.US)评级,由买入调整至买入评级, 目标价由123.00美元调整至104.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/03193147940539.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["XOMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503562238","title":"标记临床研究盘中异动 快速上涨5.77%报28.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503562238","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503562238?lang=zh_cn&edition=full","pubTime":"2025-01-16 00:37","pubTimestamp":1736959070,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日00时37分,标记临床研究股票出现波动,股价急速上涨5.77%。截至发稿,该股报28.25美元/股,成交量1.2102万股,换手率0.10%,振幅2.94%。标记临床研究股票所在的生物技术行业中,整体涨幅为0.92%。XOMA获得了与已授权给制药或生物技术公司的商业化前候选治疗相关的潜在未来经济效益。当XOMA获得未来的经济权利时,卖方将获得非稀释性、无追索权的资金,这些资金可用于推进其内部候选药物或用于一般公司用途。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116003750abac0fdc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116003750abac0fdc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XOMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503503826","title":"标记临床研究盘中异动 快速拉升5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503503826","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503503826?lang=zh_cn&edition=full","pubTime":"2025-01-14 22:42","pubTimestamp":1736865721,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日22时42分,标记临床研究股票出现波动,股价急速上涨5.20%。截至发稿,该股报26.72美元/股,成交量514股,换手率0.00%,振幅0.00%。标记临床研究股票所在的生物技术行业中,整体跌幅为0.44%。标记临床研究公司简介:XOMA Royalty Corp是一家生物技术专利使用费聚合公司,在帮助生物技术公司实现改善人类健康的目标方面发挥着重要作用。XOMA获得了与已授权给制药或生物技术公司的商业化前候选治疗相关的潜在未来经济效益。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114224201abaaaf60&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114224201abaaaf60&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XOMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502928899","title":"标记临床研究盘中异动 早盘股价大跌5.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502928899","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2502928899?lang=zh_cn&edition=full","pubTime":"2025-01-11 00:15","pubTimestamp":1736525735,"startTime":"0","endTime":"0","summary":"北京时间2025年01月11日00时15分,标记临床研究股票出现波动,股价大幅下挫5.98%。截至发稿,该股报24.20美元/股,成交量6455股,换手率0.05%,振幅1.13%。标记临床研究股票所在的生物技术行业中,整体跌幅为1.63%。标记临床研究公司简介:XOMA Royalty Corp是一家生物技术专利使用费聚合公司,在帮助生物技术公司实现改善人类健康的目标方面发挥着重要作用。XOMA获得了与已授权给制药或生物技术公司的商业化前候选治疗相关的潜在未来经济效益。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011100153595ff83c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011100153595ff83c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XOMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2493764004","title":"标记临床研究盘中异动 下午盘急速拉升5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493764004","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2493764004?lang=zh_cn&edition=full","pubTime":"2024-12-21 02:12","pubTimestamp":1734718320,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日02时12分,标记临床研究股票出现异动,股价快速上涨5.14%。截至发稿,该股报26.40美元/股,成交量2.4419万股,换手率0.21%,振幅7.21%。标记临床研究股票所在的生物技术行业中,整体涨幅为0.72%。标记临床研究公司简介:XOMA Royalty Corp是一家生物技术专利使用费聚合公司,在帮助生物技术公司实现改善人类健康的目标方面发挥着重要作用。XOMA获得了与已授权给制药或生物技术公司的商业化前候选治疗相关的潜在未来经济效益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/us/2024-12-21/doc-ineacxhi5519536.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4139","XOMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2492915551","title":"标记临床研究盘中异动 股价大跌5.30%报25.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492915551","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2492915551?lang=zh_cn&edition=full","pubTime":"2024-12-19 04:07","pubTimestamp":1734552462,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日04时07分,标记临床研究股票出现波动,股价急速下跌5.30%。截至发稿,该股报25.70美元/股,成交量2.928万股,换手率0.25%,振幅5.93%。标记临床研究股票所在的生物技术行业中,整体跌幅为1.97%。XOMA获得了与已授权给制药或生物技术公司的商业化前候选治疗相关的潜在未来经济效益。当XOMA获得未来的经济权利时,卖方将获得非稀释性、无追索权的资金,这些资金可用于推进其内部候选药物或用于一般公司用途。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219040742ab82916c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219040742ab82916c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XOMA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2491515353","title":"标记临床研究盘中异动 快速下跌5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491515353","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2491515353?lang=zh_cn&edition=full","pubTime":"2024-12-13 02:57","pubTimestamp":1734029877,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日02时57分,标记临床研究股票出现异动,股价快速下挫5.45%。截至发稿,该股报27.75美元/股,成交量9714股,换手率0.08%,振幅4.50%。标记临床研究股票所在的生物技术行业中,整体跌幅为1.09%。标记临床研究公司简介:XOMA Royalty Corp是一家生物技术专利使用费聚合公司,在帮助生物技术公司实现改善人类健康的目标方面发挥着重要作用。XOMA获得了与已授权给制药或生物技术公司的商业化前候选治疗相关的潜在未来经济效益。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213025757a1e9c648&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213025757a1e9c648&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XOMA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2489825457","title":"标记临床研究盘中异动 早盘大幅下跌5.07%报30.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489825457","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2489825457?lang=zh_cn&edition=full","pubTime":"2024-12-05 22:31","pubTimestamp":1733409074,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日22时31分,标记临床研究股票出现异动,股价快速跳水5.07%。截至发稿,该股报30.13美元/股,成交量1265股,换手率0.01%,振幅2.36%。标记临床研究股票所在的生物技术行业中,整体跌幅为0.13%。XOMA获得了与已授权给制药或生物技术公司的商业化前候选治疗相关的潜在未来经济效益。当XOMA获得未来的经济权利时,卖方将获得非稀释性、无追索权的资金,这些资金可用于推进其内部候选药物或用于一般公司用途。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120522311598e59dc9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120522311598e59dc9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XOMA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2489714344","title":"标记临床研究盘中异动 急速跳水5.24%报30.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489714344","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2489714344?lang=zh_cn&edition=full","pubTime":"2024-12-05 02:31","pubTimestamp":1733337079,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日02时31分,标记临床研究股票出现波动,股价急速跳水5.24%。截至发稿,该股报30.00美元/股,成交量3.6493万股,换手率0.31%,振幅4.96%。标记临床研究股票所在的生物技术行业中,整体涨幅为0.19%。XOMA获得了与已授权给制药或生物技术公司的商业化前候选治疗相关的潜在未来经济效益。当XOMA获得未来的经济权利时,卖方将获得非稀释性、无追索权的资金,这些资金可用于推进其内部候选药物或用于一般公司用途。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120502311998e566d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120502311998e566d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XOMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2486069880","title":"标记临床研究盘中异动 下午盘股价大涨5.45%报32.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486069880","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2486069880?lang=zh_cn&edition=full","pubTime":"2024-11-27 02:57","pubTimestamp":1732647479,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日02时57分,标记临床研究股票出现异动,股价大幅上涨5.45%。截至发稿,该股报32.70美元/股,成交量3.222万股,换手率0.27%,振幅6.80%。标记临床研究股票所在的生物技术行业中,整体涨幅为0.22%。XOMA获得了与已授权给制药或生物技术公司的商业化前候选治疗相关的潜在未来经济效益。当XOMA获得未来的经济权利时,卖方将获得非稀释性、无追索权的资金,这些资金可用于推进其内部候选药物或用于一般公司用途。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127025759abe12f97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127025759abe12f97&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XOMA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2483880503","title":"标记临床研究盘中异动 大幅下跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483880503","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2483880503?lang=zh_cn&edition=full","pubTime":"2024-11-13 23:05","pubTimestamp":1731510308,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日23时05分,标记临床研究股票出现异动,股价急速下挫5.02%。截至发稿,该股报29.69美元/股,成交量1.2428万股,换手率0.11%,振幅5.26%。标记临床研究股票所在的生物技术行业中,整体涨幅为0.21%。标记临床研究公司简介:XOMA Royalty Corp是一家生物技术专利使用费聚合公司,在帮助生物技术公司实现改善人类健康的目标方面发挥着重要作用。XOMA获得了与已授权给制药或生物技术公司的商业化前候选治疗相关的潜在未来经济效益。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111323050898e42643&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111323050898e42643&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XOMA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2482673752","title":"标记临床研究2024财年第三财季实现净利润-17.24百万美元,同比减少212.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482673752","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2482673752?lang=zh_cn&edition=full","pubTime":"2024-11-11 00:00","pubTimestamp":1731254423,"startTime":"0","endTime":"0","summary":"11月11日,标记临床研究公布财报,公告显示公司2024财年第三财季净利润为-17.24百万美元,同比减少212.89%;其中营业收入为7.20百万美元,同比增加767.47%,每股基本收益为-1.59美元。从资产负债表来看,标记临床研究总负债1.39亿美元,其中短期债务10.26百万美元,资产负债比为1.61,流动比率为0.08。机构评级:截至2024年11月11日,当前有2家机构对标记临床研究目标价做出预测,其中目标均价为86.00美元,其中最低目标价为55.00美元,最高目标价为117.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111000032a229e374&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111000032a229e374&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XOMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2481185168","title":"标记临床研究盘中异动 早盘快速跳水6.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481185168","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2481185168?lang=zh_cn&edition=full","pubTime":"2024-11-07 22:31","pubTimestamp":1730989864,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日22时31分,标记临床研究股票出现波动,股价急速下跌6.13%。截至发稿,该股报30.47美元/股,成交量2642股,换手率0.02%,振幅2.59%。标记临床研究股票所在的生物技术行业中,整体涨幅为0.06%。标记临床研究公司简介:XOMA Royalty Corp是一家生物技术专利使用费聚合公司,在帮助生物技术公司实现改善人类健康的目标方面发挥着重要作用。XOMA获得了与已授权给制药或生物技术公司的商业化前候选治疗相关的潜在未来经济效益。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107223104abaa7405&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107223104abaa7405&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XOMA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2481989119","title":"标记临床研究盘中异动 快速上涨5.06%报32.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481989119","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2481989119?lang=zh_cn&edition=full","pubTime":"2024-11-06 23:08","pubTimestamp":1730905687,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日23时08分,标记临床研究股票出现波动,股价快速拉升5.06%。截至发稿,该股报32.59美元/股,成交量4506股,换手率0.04%,振幅1.42%。标记临床研究股票所在的生物技术行业中,整体跌幅为0.42%。XOMA获得了与已授权给制药或生物技术公司的商业化前候选治疗相关的潜在未来经济效益。当XOMA获得未来的经济权利时,卖方将获得非稀释性、无追索权的资金,这些资金可用于推进其内部候选药物或用于一般公司用途。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106230807aba6c6b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106230807aba6c6b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XOMA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2479786442","title":"标记临床研究盘中异动 股价大跌6.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479786442","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2479786442?lang=zh_cn&edition=full","pubTime":"2024-10-30 21:52","pubTimestamp":1730296328,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日21时52分,标记临床研究股票出现异动,股价大幅跳水6.04%。截至发稿,该股报30.00美元/股,成交量3910股,换手率0.03%,振幅1.06%。标记临床研究股票所在的生物技术行业中,整体跌幅为0.44%。标记临床研究公司简介:XOMA Royalty Corp是一家生物技术专利使用费聚合公司,在帮助生物技术公司实现改善人类健康的目标方面发挥着重要作用。XOMA获得了与已授权给制药或生物技术公司的商业化前候选治疗相关的潜在未来经济效益。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030215209a1fae952&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030215209a1fae952&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XOMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2479195283","title":"标记临床研究盘中异动 股价大跌6.52%报28.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479195283","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2479195283?lang=zh_cn&edition=full","pubTime":"2024-10-29 21:39","pubTimestamp":1730209141,"startTime":"0","endTime":"0","summary":"北京时间2024年10月29日21时39分,标记临床研究股票出现异动,股价快速跳水6.52%。截至发稿,该股报28.25美元/股,成交量316股,换手率0.00%,振幅0.00%。标记临床研究股票所在的生物技术行业中,整体涨幅为0.11%。XOMA获得了与已授权给制药或生物技术公司的商业化前候选治疗相关的潜在未来经济效益。当XOMA获得未来的经济权利时,卖方将获得非稀释性、无追索权的资金,这些资金可用于推进其内部候选药物或用于一般公司用途。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102921390195bd825e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102921390195bd825e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XOMA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.xoma.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":-0.0395},{"period":"1year","weight":0.2541},{"period":"ytd","weight":0.5107}],"compareEarnings":[{"period":"1week","weight":-0.0233},{"period":"1month","weight":-0.0404},{"period":"3month","weight":-0.0476},{"period":"6month","weight":-0.0138},{"period":"1year","weight":0.1003},{"period":"ytd","weight":0.0741}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"XOMA Royalty Corporation于1981年在特拉华州注册成立并于2025年5月在内华达州重新注册成立。该公司是一家生物技术版税聚合商,在帮助生物技术公司实现改善人类健康的目标方面发挥着独特的作用。该公司获得了与已授权给制药或生物技术公司的预商业化和商业化治疗候选药物相关的潜在未来经济性。","yearOnYearQuotes":[{"month":1,"riseRate":0.575,"avgChangeRate":0.053986},{"month":2,"riseRate":0.475,"avgChangeRate":-0.011582},{"month":3,"riseRate":0.4,"avgChangeRate":0.005611},{"month":4,"riseRate":0.5,"avgChangeRate":-0.003258},{"month":5,"riseRate":0.55,"avgChangeRate":0.056505},{"month":6,"riseRate":0.45,"avgChangeRate":0.004369},{"month":7,"riseRate":0.439024,"avgChangeRate":-0.006946},{"month":8,"riseRate":0.475,"avgChangeRate":0.052237},{"month":9,"riseRate":0.35,"avgChangeRate":-0.010798},{"month":10,"riseRate":0.4,"avgChangeRate":-0.033618},{"month":11,"riseRate":0.525,"avgChangeRate":0.022745},{"month":12,"riseRate":0.45,"avgChangeRate":0.042998}],"exchange":"NASDAQ","name":"标记临床研究","nameEN":"XOMA Corp"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.54.0","shortVersion":"4.54.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"标记临床研究(XOMA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供标记临床研究(XOMA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"标记临床研究,XOMA,标记临床研究股票,标记临床研究股票老虎,标记临床研究股票老虎国际,标记临床研究行情,标记临床研究股票行情,标记临床研究股价,标记临床研究股市,标记临床研究股票价格,标记临床研究股票交易,标记临床研究股票购买,标记临床研究股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"标记临床研究(XOMA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供标记临床研究(XOMA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}